Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127892221 | 12789222 | 1 | I | 20160916 | 20160921 | 20160928 | 20160928 | PER | US-ELI_LILLY_AND_COMPANY-US201609008555 | ELI LILLY AND CO | 16.00 | YR | F | Y | 0.00000 | 20160928 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127892221 | 12789222 | 1 | PS | STRATTERA | ATOMOXETINE HYDROCHLORIDE | 1 | Unknown | 80 MG, QD | 6240 | MG | Y | U | 21411 | 80 | MG | CAPSULE | QD | ||
| 127892221 | 12789222 | 2 | C | INTUNIV | GUANFACINE HYDROCHLORIDE | 1 | Unknown | 2 MG, UNKNOWN | 0 | 2 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127892221 | 12789222 | 1 | Attention deficit/hyperactivity disorder |
| 127892221 | 12789222 | 2 | Attention deficit/hyperactivity disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127892221 | 12789222 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127892221 | 12789222 | Suicidal ideation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127892221 | 12789222 | 1 | 20160701 | 20160921 | 0 | |
| 127892221 | 12789222 | 2 | 20160701 | 20160921 | 0 |